Press releases
-
2 February 2012 - Paris (France)Ipsen’s fourth quarter and full year 2011 sales and other significant developments
-
27 January 2012 - Paris (France)Ipsen acknowledges Tanakan® delisting in France
-
24 January 2012 - Paris (France)Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement
-
23 January 2012 - Paris (France)Fifth meeting in the “Biological Complexity” series jointly organised by the Fondation Ipsen and the Salk Institute for Biological Studies
-
5 January 2012 - Dijon and Paris (France)Oncodesign and Ipsen enter into a research collaboration for the development of new therapeutic agents against the LRRK2 Parkinson's disease target
-
4 January 2012 - Paris (France)Ipsen announces its corporate agenda for 2012
Registration Document 2010
Publications
CONTACT US
Didier Véron
Director, Public Affairs and Corporate Communications
Tel.: +33 (0)1 58 33 51 16
Fax: +33 (0)1 58 33 50 58
Send an e-mail
Pipeline
